The advent of non-invasive brain imaging methods in the 1980s resulted in increased recognition of cerebral venous thrombosis. Before that time, only physicians with a high index of suspicion considered the diagnosis in patients with otherwise unexplained headache, focal de®cits, seizures, impaired consciousness, or combinations of these features 1 . This paper and the three which follow it review the modern approaches to diagnosis and treatment.
PATHOGENESIS
Virchow's triad of causes of thrombosis is damage to vessel wall, disorders of coagulation and stagnant¯ow. In contrast to cases in which the precipitant is arterial thrombosis, damage to the vessel wall is a causal factor in only about 10% of patients with cerebral venous thrombosis 2 ; in those cases the underlying disease consists of infection, in®ltration, or trauma. Much more important are disorders of coagulation (70%; see Box 1) 2 . The most common inherited coagulation defect is factor V Leiden mutation, which is found in some 20% of patients without obvious other causes 3±5 . Stagnant¯ow contributes not more than a few per cent (episodes associated with dehydration or with dural puncture, sometimes in combination with hyperosmolar contrast agents). In 20% of patients no contributing factors can be identi®ed and the cause remains a mystery.
Often there is not a single cause but a combination of contributing factorsÐfor example, the postpartum period and protein S de®ciency 6 ; pregnancy and Behc Ëet's disease 7 ; oral contraceptive drugs and the factor V Leiden mutation 8,9 , or the same combination with dural puncture as a third factor 10 . The risk of cerebral venous thrombosis in the postpartum period increases with maternal age 11 and with performance of caesarean section 12 .
In neonates, cerebral venous thrombosis is usually associated with acute systemic illness such as shock or dehydration; in older children the most frequent underlying conditions are local infection (the leading cause until the antibiotic era), coagulopathy 13, 14 and in Mediterranean countries Behc Ëet's disease 15 .
PRESENTATION
The clinical features of cerebral venous thrombosis consist essentially of headache, focal de®cits, seizures, and impairment of consciousness, in various combinations and degrees of severity. The symptoms and signs depend to some extent on which sinus is affected, and to an important extent on whether the thrombotic process is limited to the dural sinus or extends to the cortical veins 2 .
In the case of the superior sagittal sinus (which is most often affected), in 70±80% of the total 16, 17 , sinus thrombosis alone will lead to the syndrome of intracranial hypertension, i.e. headache and papilloedema. Up to 30% of patients with so-called`benign intracranial hypertension' (BIH) may in fact have sinus thrombosis 18 . An anatomical obstruction within the superior sagittal sinus may exist in up to 50% of all patients with BIH 19, 20 , but the cause of the obstruction is not necessarily thrombosis. Those with underlying venous thrombosis are more often non-obese or male, but are otherwise indistinguishable from patients with idiopathic BIH 18 . Papilloedema can cause transient visual obscurations and sometimes irreversible constriction of visual ®elds, beginning in the inferonasal quadrants 1 . The increased pressure of the cerebrospinal¯uid (CSF) may also give rise to VIth nerve palsies, and sometimes to other cranial nerve de®cits. The onset of the headache is usually gradual, but in up to 15% of patients it is sudden and may initially suggest the diagnosis of a ruptured aneurysm 21 .
Involvement of cortical veins causes one or more areas of venous infarction, with or without haemorrhagic transformation. If the affected veins drain into the sagittal sinus the venous infarcts are typically located near the midline in the Rolandic and parieto±occipital regions, often on both sides. In the case of the lateral sinus, the venous infarct is usually located in the posterior temporal area 22 . If the thrombotic process extends to the petrosal sinus the trigeminal nerve may be affected, and in the case of the jugular vein the cranial nerves IX±XI 2 .
Clinically the infarcts manifest themselves through epileptic seizures, or through focal de®cits such as hemiparesis or dysphasia. If unilateral weakness develops (with thrombosis originating in the superior sagittal sinus), it tends to predominate in the leg, in keeping with the parasagittal location of most venous infarcts. Obstruction of cortical veins draining into the posterior part of the superior sagittal sinus or into the lateral sinus will commonly lead to hemianopia, dysphasia, or a confusional state. Impairment of consciousness may result from multiple lesions in the cerebral hemispheres, or from transtentorial herniation and compression of the brain stem. Either epilepsy or a focal de®cit is a presenting feature in 10±15% of patients 23 ; in the course of the illness seizures occur in 10±60% of reported series and focal de®cits in 30±80% 16, 17, 23, 24 .
Involvement of the cortical veins alone, without sinus thrombosis and its associated signs of increased CSF pressure, is an extremely rare occurrence 16, 23 ; recently four such cases have been published together, from different centres 25 . Thrombosis of the deep venous system, including the great vein of Galen, may lead to bilateral haemorrhagic infarctions of corpus striatum, thalamus, hypothalamus, the ventral corpus callosum, the medial occipital lobe and the upper part of the cerebellum 26 . Needless to say, in those instances the clinical picture is dominated by deep coma and disturbance of eye movements and pupillary re¯exes. Partial syndromes exist and can be survived, sometimes with surprisingly few sequelae 16, 27, 28 . Thrombosis of cerebellar veins leads to clinical features resembling those with arterial-territory infarcts in the cerebellum (dominated by headache, vertigo, vomiting and ataxia, sometimes followed by impaired consciousness), but with a more gradual onset 1, 29, 30 .
PROGNOSIS
Death rates in different series range between 5% and 30%, and probably depend more on case mix than on treatment 16, 17, 23, 24 . Causes of death can be the underlying condition, the brain lesion, secondary complications, or a combination of these 2 . The same variation is found in reported proportions of patients with complete recovery (50±80%). Residual de®cits consist mostly of hemispheral de®cits or visual impairment from optic atrophy.
The risk of recurrence has seldom been addressed systematically. In a single longitudinal study spanning an average period of 6 1 ¤ 2 years, 9 of 77 patients (12%) experienced a second episode; 3 of them had Behc Ëet's disease 31 . In young women with a peripartum episode of cerebral venous thrombosis a dif®cult question is whether a subsequent pregnancy ought to be discouraged. The sparse evidence available does not warrant such advice 2, 32 , although in patients with the factor V Leiden mutation the risk of a recurrent episode is probably higher than average 5 . 
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